CUA Speaker Tour: Theragnostics (PSMA Imaging: When should I use it and what are the pitfalls?)
SESSION #1: PSMA Imaging: when should I use it and what are the pitfalls?
Professor Michael Hofman, MBBS, FRACP, FAANMS, FICIS
PET Modality Lead, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging
Director, Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC)
Peter MacCallum Cancer Centre, Melbourne, Australia
Sir Peter MacCallum Department of Oncology, The University of Melbourne